NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-242-2012-0-US-01 Recurrent Mutation In Mitogen-Activated Protein Kinase Kinase Kinase 5 (MAP3K5) For Diagnosing And Treating Melanoma US 61/708,785 Abandoned
NCI E-191-2002-0-US-10 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF. US CON 13/632,293 8609716 Expired PDF
NIAID E-103-2014-1-US-01 Antibody Evolution Immunogens US 61/708,466 Abandoned
NIAID E-102-2014-1-US-01 Clonal Lineage Of CD4 Binding Site Antibodies For Use As Templates For HIV-1 Vaccine Design US 61/708,413 Abandoned
NICHD E-271-2011-0-PCT-02 Influenza Vaccine PCT PCT PCT/US2012/057863 Expired
NINDS E-143-2002-1-JP-14 Method For the Treatment of Multiple Sclerosis JP DIV 2012-217520 Abandoned
NINDS E-249-2011-0-PCT-02 Method of Treating Multiple Sclerosis By Intrathecal Depletion Of B Cells And Biomarkers To Select Patients With Progressive Multiple Sclerosis PCT PCT PCT/US2012/057583 Expired
NINDS E-249-2011-0-EP-03 Method of Treating Multiple Sclerosis By Intrathecal Depletion Of B Cells And Biomarkers To Select Patients With Progressive Multiple Sclerosiss EP National Stage 12769299.4 Abandoned
NCI E-236-2012-0-US-01 Mesothelin Antibodies And Methods For Eliciting Potent Antitumor Activity US 61/706,396 Abandoned
NCI E-261-2005-2-US-04 Method For Diagnosing And Monitoring The Progression Of Cancer US CON 13/627,595 8617831 Issued PDF
NCI E-147-2012-2-PCT-01 Methods Of Treating Periodontal Inflammation And Periodontal Bone Loss PCT PCT COMB PCT/US2012/057329 Expired
NHLBI E-214-2012-0-US-01 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) INJURY US 61/705,555 Abandoned
NIDCR E-232-2011-1-US-01 Methods For The Diagnosis And Treatment Of Sjogren's Syndrome US 61/705,517 Abandoned
NIAID E-293-2011-2-IN-05 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN BASED VACCINES IN National Stage 3192/DELNP/2014 Issued
NIAID E-293-2011-2-IT-14 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES IT EP 12834398.5 Issued
NIAID E-293-2011-2-IE-13 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES IE EP 12834398.5 Issued
NIAID E-293-2011-2-BE-08 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES BE EP 12834398.5 Issued
NIAID E-293-2011-2-DE-10 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES DE EP 12834398.5 Issued
NIAID E-293-2011-2-FR-11 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES FR EP 12834398.5 Issued
NIAID E-293-2011-2-GB-12 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES GB EP 12834398.5 Issued
NIAID E-293-2011-2-CH-09 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES CH EP 12834398.5 Issued
NIAID E-293-2011-2-EP-04 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES EP National Stage 12834398.5 Issued
NIAID E-293-2011-2-CN-03 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES CN National Stage 201280057703.7 Issued
NICHD E-042-2013-0-US-03 Injectable Dendrimer Hydrogel Nanoparticles US National Stage 13/636,715 9526794 Issued PDF
NIAID E-293-2011-2-PCT-01 NOVEL INFLUENZA HEMAGGLUTININ PROTEIN-BASED VACCINES PCT PCT COMB PCT/US2012/056822 Expired
NIA E-012-2012-0-EP-09 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders EP National Stage 12761739.7 Issued
NIA E-012-2012-0-JP-06 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders JP National Stage 2014-531244 Issued
NIA E-012-2012-0-AU-03 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders AU National Stage 2012311483 Issued
NIA E-012-2012-0-CN-05 Combination Therapy Using Immunoglobulin and C1-inhibitor CN National Stage 201280046349.8 Issued
NIA E-012-2012-0-PCT-02 Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders PCT PCT PCT/EP2012/068643 Expired
NICHD E-057-2008-0-US-14 Method for Treating Uterine Fibroids US CON 13/622,892 8722653 Abandoned PDF
NCI E-340-2007-0-US-09 Human Prostate Cancer MicroRNA Signature US DIV 13/622,487 Abandoned
NIAID E-285-2012-0-US-01 I0E8-Epitope-Based Immunogens And Probes And Their Uses US 61/702,703 Abandoned
NCATS E-529-2013-0-US-01 The Use of Boronate Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease US 61/702,295 Abandoned
NCATS E-529-2013-1-US-01 Use of Epoxyketone Proteasome Inhibitors in the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease US 61/702,297 Abandoned
NICHD E-226-2010-0-EP-03 Tractography Based Transit Time Determination EP National Stage 12777958.5 Issued
NICHD E-226-2010-0-GB-08 Tractography Based Transit Time Determination GB EP 12777958.5 Issued
NICHD E-226-2010-0-DE-06 Tractography Based Transit Time Determination DE EP 12777958.5 Issued
NICHD E-226-2010-0-FR-07 Tractography Based Transit Time Determination FR EP 12777958.5 Issued
NHGRI E-099-2009-0-US-02 Device and Method for Direct Measurement of Isotopes of Expired Gases US DIV 13/620,490 8721988 Abandoned PDF
NICHD E-226-2010-0-PCT-02 Tractography Based Transit Time Determination PCT PCT PCT/US2012/055458 Expired
NCI E-230-2012-0-US-01 T Cells Receptors Recognizing MHC Class II-Restricted Mage-A3 US 61/701,056 Abandoned
NCI E-054-2011-0-US-01 Methods And Compositions For The Treatment Of Cancer US 61/701,528 Abandoned
NCI E-055-2011-0-US-01 Brachyury Protein, Non-Poxvirus Non-Yeast Vectors Encoding Brachyury Protein, And Their Use US 61/701,525 Abandoned
NCI E-263-2011-0-EP-05 Pseudomonas Exotoxin A With Less Immunogenic B Cell Epitopes EP National Stage 12766780.6 Issued
NCI E-292-2007-0-DE-40 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY DE EP 12184319.7 Issued
NCI E-292-2007-0-FR-39 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY FR EP 12184319.7 Issued
NCI E-292-2007-0-IT-42 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY IT EP 12184319.7 Issued
NCI E-292-2007-0-GB-41 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY GB EP 12184319.7 Issued
NCI E-292-2007-0-ES-43 DELETIONS IN DOMAIN II OF PSEUDOMONAS EXOTOXIN A THAT REDUCE NON-SPECIFIC TOXICITY ES EP 12184319.7 Issued